Caligiuri
Antonio Caligiuri, Parma IT
Patent application number | Description | Published |
---|---|---|
20100173880 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF - Alkaloid aminoester compounds which act as muscarinic receptor antagonists are useful for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases. | 07-08-2010 |
20110311461 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF - The present invention relates to alkaloid aminoester compounds which act as muscarinic receptor antagonists, processes for their preparation, compositions comprising them, and therapeutic uses thereof. | 12-22-2011 |
20130196978 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF - Alkaloid aminoester compounds which act as muscarinic receptor antagonists are useful for the prevention and/or treatment of a broncho-obstructive or inflammatory diseases. | 08-01-2013 |
Giuseppina Caligiuri, Paris FR
Patent application number | Description | Published |
---|---|---|
20110229981 | DETECTION OF SHED CD31, DIAGNOSIS OF ATHEROTHROMBOSIS AND AUTOIMMUNE DISORDERS, AND METHODS FOR ANALYZING SIGNALING PATHWAYS - The present invention stems from the finding that the extracellular domain of CD31 proteins present on blood leukocytes is shed and released in the circulation as a soluble form of CD31. A method for detecting shed CD31 is further disclosed. The invention therefore relates to a method for detecting a shed ectodomain of a transmembrane protein such as CD31 and to the use of such a method as a diagnostic tool. The invention further provides methods for determining whether a candidate protein is part of a molecular complex. | 09-22-2011 |
20120010136 | USE OF CD31 PEPTIDES IN THE TREATMENT OF THROMBOTIC AND AUTOIMMUNE DISORDERS - The present invention stems from the finding that the extracellular domain of CD31 proteins present on blood leukocytes is shed and released in the circulation as a soluble form of CD31. The invention relates to peptides corresponding to fragments of CD31 that inhibit T-cell response, and to their use in the treatment of thrombotic disorders such as atherothrombosis and autoimmune disorders. | 01-12-2012 |
20150065374 | Detection of Platelet-Derived Shed CD31 - The present invention relates to various soluble forms of CD31, including a novel form which is shed by activated platelets and released into the circulation. Methods for detecting said soluble forms of CD31 are disclosed, as are methods of specifically 1 detecting said platelet-derived shed CD31 and the use of such methods as a diagnostic tool. | 03-05-2015 |
Jeanne M. Caligiuri, Las Vegas, NV US
Patent application number | Description | Published |
---|---|---|
20130273218 | MICROWAVEABLE HEAT RETENTIVE CONTAINER - The present invention is directed to a portable and microwaveable container into which a vessel may be inserted, and which assists in preserving or prolonging elevated temperatures of the contents of the vessel for an extended period of time. The container includes a receptacle area, or opening, into which the vessel is inserted. The container of the present invention may be heated, such as in a microwave oven, and once heated, a vessel containing a warmed food product, typically an elevated temperature liquid, may be inserted. The container of the present invention internally contains a microwaveable absorbing material which retains thermal energy. Once heated, the container passively improves the heat retention of the contents of the inserted vessel. | 10-17-2013 |
Marcello Caligiuri, Ferno (varese) IT
Patent application number | Description | Published |
---|---|---|
20100180716 | Protection Device with Aerodynamic Effect for a Motor Vehicle - A protection device is described for the ends of a handlebar (M) of a motorcycle, of the type comprising a protection member which can be attached to the ends of said handlebar (M), which comprises a structural protection member ( | 07-22-2010 |
Maureen Caligiuri, Reading, MA US
Patent application number | Description | Published |
---|---|---|
20090030067 | Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane - The present invention describes a method of prevention and/or treatment of a cancer or a tumor, and in particular a combination therapy, methods, compositions and pharmaceutical packages comprising a taxane and certain platinum-based chemotherapeutic agents. | 01-29-2009 |
Michael A. Caligiuri, Columbus, OH US
Patent application number | Description | Published |
---|---|---|
20080206205 | Cd34(+) Cells And Their Methods Of Use | 08-28-2008 |
20080299660 | Methods For Transfecting Natural Killer Cells - Methods for stably transfecting mammalian natural killer cells comprising: transfecting a packaging cell line with a retroviral expression vector; culturing the transfected packaging cell line in a cell culture medium; and culturing the mammalian natural killer cells with the cell culture medium. Natural killer cells transfected according to the disclosed methods are also provided. | 12-04-2008 |
20090004182 | Methods to Treat or Prevent Viral-Associated Lymphoproliferative Disorders - The disclosure relates to methods to prevent, treat, or slow the progression viral-associated lymphoproliferative disorders, EBV-associated lymphoproliferative disorders, and post-transplant lymphoproliferative disorders. In the methods, a TGF-β antagonist, e.g., an anti-TGF-β antibody is administered to a subject. Methods for treating viral-associated lymphoproliferative disorders and for enhancing T-cell responsiveness to a viral-associated lymphoproliferative disorder by administering a TGF-β antagonist are also described. | 01-01-2009 |